Bayer Cropscience Limited (BAYERCROP) - Total Assets

Latest as of September 2025: Rs51.91 Billion INR ≈ $561.39 Million USD

Based on the latest financial reports, Bayer Cropscience Limited (BAYERCROP) holds total assets worth Rs51.91 Billion INR (≈ $561.39 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check BAYERCROP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Bayer Cropscience Limited - Total Assets Trend (2004–2025)

This chart illustrates how Bayer Cropscience Limited's total assets have evolved over time, based on quarterly financial data. Explore Bayer Cropscience Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.

Bayer Cropscience Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Bayer Cropscience Limited's total assets of Rs51.91 Billion consist of 85.2% current assets and 14.8% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs6.93 Billion 17.0%
Accounts Receivable Rs9.57 Billion 18.3%
Inventory Rs23.62 Billion 45.0%
Property, Plant & Equipment Rs4.27 Billion 8.2%
Intangible Assets Rs1.36 Billion 2.6%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2004–2025)

This chart illustrates how Bayer Cropscience Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BAYERCROP company net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Bayer Cropscience Limited's current assets represent 85.2% of total assets in 2025, an increase from 73.0% in 2004.
  • Cash Position: Cash and equivalents constituted 17.0% of total assets in 2025, up from 11.5% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2004.
  • Asset Diversification: The largest asset category is inventory at 45.0% of total assets.

Bayer Cropscience Limited Competitors by Total Assets

Key competitors of Bayer Cropscience Limited based on total assets are shown below.

Company Country Total Assets
Chambal Fertilizers & Chemicals Limited
NSE:CHAMBLFERT
India Rs138.53 Billion
Stanley Fertilizer Co Ltd
SHE:002588
China CN¥15.67 Billion
Kaveri Seed Company Limited
NSE:KSCL
India Rs26.42 Billion
Insecticides (India) Limited
NSE:INSECTICID
India Rs19.97 Billion
Boa Safra Sementes S.A
SA:SOJA3
Brazil R$3.46 Billion
Nongwoobio Co. Ltd
KQ:054050
Korea ₩344.76 Billion
Graines Voltz S.A
PA:GRVO
France €168.49 Million
Nusa Palapa Gemilang PT Tbk
JK:NPGF
Indonesia Rp317.06 Billion

Bayer Cropscience Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.29 2.22 2.15
Quick Ratio 1.43 1.57 1.58
Cash Ratio 0.34 0.44 0.00
Working Capital Rs24.82 Billion Rs25.23 Billion Rs18.58 Billion

Bayer Cropscience Limited - Advanced Valuation Insights

This section examines the relationship between Bayer Cropscience Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 6.63
Latest Market Cap to Assets Ratio 0.04
Asset Growth Rate (YoY) 14.1%
Total Assets Rs52.46 Billion
Market Capitalization $2.07 Billion USD

Valuation Analysis

Below Book Valuation: The market values Bayer Cropscience Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Bayer Cropscience Limited's assets grew by 14.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Bayer Cropscience Limited (2004–2025)

The table below shows the annual total assets of Bayer Cropscience Limited from 2004 to 2025.

Year Total Assets Change
2025-03-31 Rs52.46 Billion
≈ $567.32 Million
+14.11%
2024-03-31 Rs45.97 Billion
≈ $497.16 Million
-1.74%
2023-03-31 Rs46.79 Billion
≈ $505.97 Million
+7.48%
2022-03-31 Rs43.53 Billion
≈ $470.75 Million
+2.68%
2021-03-31 Rs42.39 Billion
≈ $458.46 Million
+10.52%
2020-03-31 Rs38.36 Billion
≈ $414.82 Million
+32.20%
2019-03-31 Rs29.02 Billion
≈ $313.79 Million
+14.47%
2018-03-31 Rs25.35 Billion
≈ $274.13 Million
-10.29%
2017-03-31 Rs28.25 Billion
≈ $305.56 Million
+15.88%
2016-03-31 Rs24.38 Billion
≈ $263.69 Million
-12.09%
2015-03-31 Rs27.74 Billion
≈ $299.95 Million
+16.20%
2014-03-31 Rs23.87 Billion
≈ $258.13 Million
-1.16%
2013-03-31 Rs24.15 Billion
≈ $261.17 Million
+31.20%
2012-03-31 Rs18.41 Billion
≈ $199.06 Million
+16.93%
2011-03-31 Rs15.74 Billion
≈ $170.25 Million
+45.34%
2010-03-31 Rs10.83 Billion
≈ $117.14 Million
+15.57%
2009-03-31 Rs9.37 Billion
≈ $101.36 Million
+9.68%
2008-03-31 Rs8.55 Billion
≈ $92.42 Million
+29.61%
2007-03-31 Rs6.59 Billion
≈ $71.30 Million
+0.02%
2006-03-31 Rs6.59 Billion
≈ $71.29 Million
+14.74%
2005-03-31 Rs5.75 Billion
≈ $62.13 Million
-20.11%
2004-03-31 Rs7.19 Billion
≈ $77.77 Million
--

About Bayer Cropscience Limited

NSE:BAYERCROP India Agricultural Inputs
Market Cap
$2.07 Billion
Rs191.84 Billion INR
Market Cap Rank
#6199 Global
#272 in India
Share Price
Rs4268.70
Change (1 day)
+1.41%
52-Week Range
Rs4209.40 - Rs6482.50
All Time High
Rs6836.59
About

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance… Read more